|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 54.78 USD | -8.24% |
|
55.52 | +1.35% |
| 07-21 | Barclays Initiates Forte Biosciences at Overweight With $74 Price Target | MT |
| 07-09 | Forte Biosciences, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORTE BIOSCIENCES, INC. | Bio Therapeutic Drugs | -8.24% | +12.12% | +100.88% | +409.58% | -92.77% | 1.34B |  | | |
- Stock Market
- Stocks
- FBRX Stock
- Charts Forte Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
